Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shaji Kumar, Ravi Vij, Jonathan L. Kaufman, Joseph Mikhael, Thierry Facon, Brigitte Pegourie, Lotfi Benboubker, Cristina Gasparetto, Martine Amiot, Philippe Moreau, Susan Diehl, Stefanie Alzate, Jeremy A Ross, Martin Dunbar, Ming Zhu, Suresh K Agarwal, Joel Leverson, Paulo Cesar Maciag, Maria E. Verdugo, Cyrille Touzeau
Institutions: Mayo Clinic, Washington University in St. Louis, Winship Cancer Institute, Mayo Clinic in Arizona, Centre Hospitalier Universitaire de Grenoble, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, Duke Medical Center, Centre Hospitalier Universitaire de Nantes, AbbVie (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890956331